I want to know the answer to the following question:
What enables a drug's owner to recover R&D costs?
All the background I'm provided with is that "Often the owner of the branded drug will introduce a generic version before the patent expires in order to get a head start in the generic market.". Is that enough to answer the question?
Answer: no